Hong Du Selected Research

Prostatic Neoplasms (Prostate Cancer)

8/2023	The long transcript of lncRNA TMPO-AS1 promotes bone metastases of prostate cancer by regulating the CSNK2A1/DDX3X complex in Wnt/β-catenin signaling.
1/2023	BHLHE22 drives the immunosuppressive bone tumor microenvironment and associated bone metastasis in prostate cancer.
10/2021	Corrigendum to "FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling" [Cancer Lett. 402 (2017) 166-176].
10/2021	Identification of potential autophagy-associated lncRNA in prostate cancer.
1/2021	m6 A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization.
1/2020	SMAD3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-β signaling promotes prostate cancer bone metastasis.
1/2017	FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling.
2/2016	N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells.
7/2014	Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong Du Research Topics

Disease

88	Neoplasms (Cancer) 01/2024 - 10/2005
45	Stomach Neoplasms (Stomach Cancer) 01/2024 - 03/2009
37	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2011
27	Infections 03/2024 - 04/2008
23	Inflammation (Inflammations) 04/2024 - 06/2004
13	Carcinogenesis 11/2022 - 12/2006
11	Hemorrhagic Fever with Renal Syndrome (HFRS) 01/2023 - 01/2013
11	Carcinoma (Carcinomatosis) 01/2019 - 03/2009
10	Wolman Disease (Wolman's Disease) 01/2024 - 07/2002
9	Prostatic Neoplasms (Prostate Cancer) 08/2023 - 07/2014
6	Type 2 Diabetes Mellitus (MODY) 06/2016 - 02/2007
5	Hemorrhage 05/2021 - 06/2008
5	Pneumonia (Pneumonitis) 01/2021 - 09/2005
4	Lymphatic Metastasis 12/2023 - 12/2013
4	Lung Neoplasms (Lung Cancer) 01/2023 - 03/2009
4	Atherosclerosis 11/2021 - 01/2004
4	Body Weight (Weight, Body) 01/2020 - 02/2004
4	Breast Neoplasms (Breast Cancer) 10/2019 - 03/2011
4	Adenocarcinoma 12/2013 - 09/2007
3	Pain (Aches) 04/2024 - 11/2015
3	Hypoxia (Hypoxemia) 11/2023 - 02/2016
3	Hypertension (High Blood Pressure) 11/2023 - 01/2012
3	Pathologic Constriction (Stenosis) 09/2023 - 01/2014
3	COVID-19 09/2021 - 12/2020
3	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 02/2007
3	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2020 - 04/2008
3	B-Cell Lymphoma (Lymphoma, B Cell) 03/2019 - 10/2014
3	Insulin Resistance 01/2016 - 01/2012
3	Fibrosis (Cirrhosis) 01/2016 - 02/2007
3	Hepatomegaly 11/2015 - 07/2002
3	Adenoma (Adenomas) 08/2011 - 02/2007
3	Emphysema 05/2011 - 09/2005
2	Aneurysm (Aneurysms) 01/2024 - 06/2008
2	Cardiotoxicity 01/2024 - 01/2022
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2023 - 03/2019
2	Glioma (Gliomas) 10/2023 - 01/2019
2	Hyperlipidemias (Hyperlipidemia) 09/2023 - 12/2003
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2020
2	Myocardial Infarction 04/2022 - 01/2015
2	Atrial Fibrillation 03/2022 - 01/2021
2	Hypertrophy 02/2022 - 01/2016

Drug/Important Bio-Agent (IBA)

26	Biomarkers (Surrogate Marker)IBA 10/2023 - 09/2007
25	Proteins (Proteins, Gene)FDA Link 05/2024 - 02/2007
18	Sterol Esterase (Hormone-Sensitive Lipase)IBA 01/2024 - 01/2004
15	EnzymesIBA 05/2024 - 01/2004
15	CytokinesIBA 01/2022 - 09/2007
14	MicroRNAs (MicroRNA)IBA 05/2022 - 01/2011
12	LipidsIBA 01/2024 - 07/2002
12	Long Noncoding RNAIBA 08/2023 - 01/2018
10	Messenger RNA (mRNA)IBA 04/2024 - 02/2009
7	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 01/2019
7	ChemokinesIBA 01/2021 - 09/2007
6	LigandsIBA 12/2023 - 02/2014
6	CateninsIBA 08/2023 - 01/2017
5	ImmunosorbentsIBA 05/2024 - 01/2014
5	Small Interfering RNA (siRNA)IBA 01/2023 - 11/2011
5	Carbapenems (Carbapenem Antibiotics)IBA 01/2023 - 01/2015
5	Insulin (Novolin)FDA Link 01/2021 - 01/2013
5	Doxycycline (Periostat)FDA LinkGeneric 01/2012 - 06/2004
4	Indicators and Reagents (Reagents)IBA 12/2023 - 01/2014
4	Circular RNAIBA 10/2023 - 02/2022
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 02/2009
4	oxidized low density lipoproteinIBA 11/2021 - 12/2003
4	Interleukin-6 (Interleukin 6)IBA 11/2021 - 04/2011
4	Triglycerides (Triacylglycerol)IBA 01/2021 - 10/2004
4	DNA (Deoxyribonucleic Acid)IBA 06/2016 - 01/2011
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2015 - 02/2004
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2023 - 12/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2023 - 05/2016
3	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 03/2019
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2018
3	Tigecycline (Tygacil)FDA Link 01/2023 - 01/2019
3	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2013
3	Competitive Endogenous RNAIBA 05/2022 - 09/2021
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 05/2011
3	Retinaldehyde (Retinal)IBA 04/2020 - 06/2008
3	InterleukinsIBA 11/2019 - 01/2017
3	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 06/2005
3	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 02/2007
3	CholesterolIBA 09/2011 - 12/2003
3	eribulin FDA Link 03/2011 - 03/2011
3	Histidine (L-Histidine)FDA Link 05/2007 - 12/2006
2	Analgesics (Analgesic Drugs)IBA 04/2024 - 01/2022
2	mesaconitineIBA 01/2024 - 01/2022
2	EndonucleasesIBA 12/2023 - 03/2019
2	AntioxidantsIBA 11/2023 - 09/2018
2	LipopolysaccharidesIBA 02/2023 - 01/2022
2	Pyruvic Acid (Pyruvate)IBA 01/2023 - 01/2022
2	Peptides (Polypeptides)IBA 01/2023 - 01/2019
2	ApoferritinsIBA 11/2022 - 01/2020

Therapy/Procedure

27	Therapeutics 01/2023 - 04/2002
6	Stents 01/2024 - 03/2014
5	Drug Therapy (Chemotherapy) 01/2022 - 08/2012
4	Lasers (Laser) 11/2022 - 12/2004
3	Neoadjuvant Therapy 03/2023 - 08/2012
3	Light Coagulation 11/2022 - 12/2004
3	Hematopoietic Stem Cell Transplantation 11/2015 - 12/2007
3	Transplantation 11/2015 - 01/2012
2	Aftercare (After-Treatment) 09/2023 - 01/2013
2	Length of Stay 12/2022 - 05/2021